Pricing Log in Create free account

MetaVia Inc. (MTVA) vs Theriva Biologics, Inc. (TOVX)

MetaVia Inc. and Theriva Biologics, Inc. are both Biotechnology companies. MetaVia Inc. and Theriva Biologics, Inc. are of similar size ($9.7M and $9.0M). MetaVia Inc. has negative trailing earnings, so its P/E is not meaningful; Theriva Biologics, Inc. trades at 0.1×. Across the 11 metrics below, Theriva Biologics, Inc. leads on 8 and MetaVia Inc. on 3.

Valuation

Metric MTVA TOVX Biotechnology median
P/E n/m 0.15 8.50
P/S n/m n/m 9.71
P/B 1.10 0.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.09 0.01 0.64
EV/Sales n/m n/m 9.21
Earnings yield (178.24%) 672.90% (33.15%)
Free cash flow yield (211.89%) (132.61%) (25.50%)

Profitability

Metric MTVA TOVX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (175.68%) (115.11%) (56.36%)
Return on assets (91.06%) (37.14%) (48.04%)
Return on invested capital 0.00% (301.72%) 0.00%

Growth

Metric MTVA TOVX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 81.23% 89.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTVA TOVX Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 2.06 1.13 4.72
Net debt to EBITDA 0.75 0.48 0.96

Dividend

Metric MTVA TOVX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MTVA TOVX Biotechnology median
Market cap 9.03m 9.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack